Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents

World Journal of Gastroenterology

Volumn 22, Issue 39, 2016, Pages 8812-8819

  Di Martino, Michele ^a   Pacifico, Lucia ^a   Bezzi, Mario ^a   Di Miscio, Rossella ^a   Sacconi, Beatrice ^a   Chiesa, Claudio ^b   Catalano, Carlo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

Author keywords

Children; Magnetic resonance imaging PDFF; Magnetic resonance spectroscopy; Non alcoholic fatty liver disease; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INSULIN; TRIACYLGLYCEROL; PROTON;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; INTRAPERITONEAL FAT; LIVER BIOPSY; MALE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON DENSITY FAT FRACTION; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOLOGICAL PARAMETERS; SUBCUTANEOUS FAT; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VALIDATION STUDY; VOXEL BASED MORPHOMETRY; BIOPSY; COMPLICATION; DIAGNOSTIC IMAGING; FATTY LIVER; LIVER; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE;

ADOLESCENT; BIOPSY; CHILD; FATTY LIVER; FEMALE; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PROTONS; REFERENCE VALUES; ROC CURVE;

EID: 84992648234     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i39.8812     Document Type: Article

References (40)

1. Giorgio V, Prono F, Graziano F, Nobili V. Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr 2013; 13: 40 [PMID: 23530957 DOI: 10.1186/1471-2431-13-40]
2. Widhalm K, Ghods E. Nonalcoholic fatty liver disease: A challenge for pediatricians. Int J Obes (Lond) 2010; 34: 1451-1467 [PMID: 20838401 DOI: 10.1038/ijo.2010.185]
3. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: A follow-up study for up to 20 years. Gut 2009; 58: 1538-1544 [PMID: 19625277 DOI: 10.1136/gut.2008.171280]
4. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology 2009; 50: 1282-1293 [PMID: 19637286 DOI: 10.1002/hep.23119]
5. Kotronen A, Yki-Järvinen H. Fatty liver: A novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008; 28: 27-38 [PMID: 17690317 DOI: 10.1161/ATVBAHA.107.147538]
6. Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, Bettencourt R, Changchien C, Brenner DA, Sirlin C, Loomba R. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013; 58: 1930-1940 [PMID: 23696515 DOI: 10.1002/hep.26455]
7. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011; 34: spcone
8. Yokoo T, Shiehmorteza M, Hamilton G, Wolfson T, Schroeder ME, Middleton MS, Bydder M, Gamst AC, Kono Y, Kuo A, Patton HM, Horgan S, Lavine JE, Schwimmer JB, Sirlin CB. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 2011; 258: 749-759 [PMID: 21212366 DOI: 10.1148/radiol.10100659]
9. Meisamy S, Hines CD, Hamilton G, Sirlin CB, McKenzie CA, Yu H, Brittain JH, Reeder SB. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011; 258: 767-775 [PMID: 21248233 DOI: 10.1148/radiol.10100708]
10. Hines CD, Frydrychowicz A, Hamilton G, Tudorascu DL, Vigen KK, Yu H, McKenzie CA, Sirlin CB, Brittain JH, Reeder SB. T(1) independent, T(2) (∗) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 2011; 33: 873-881 [PMID: 21448952 DOI: 10.1002/jmri.22514]
11. 1H MR spectrum. NMR Biomed 2011; 24: 784-790 [PMID: 21834002 DOI: 10.1002/nbm.1622]
12. Cali AM, De Oliveira AM, Kim H, Chen S, Reyes-Mugica M, Escalera S, Dziura J, Taksali SE, Kursawe R, Shaw M, Savoye M, Pierpont B, Constable RT, Caprio S. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 2009; 49: 1896-1903 [PMID: 19434725 DOI: 10.1002/hep.22858]
13. Chabanova E, Bille DS, Thisted E, Holm JC, Thomsen HS. (1)H MRS assessment of hepatic steatosis in overweight children and adolescents: comparison between 3T and open 1T MR-systems. Abdom Imaging 2013; 38: 315-319 [PMID: 22736224 DOI: 10.1007/s00261-012-9930-2]
14. Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, Gamst AC, Middleton M, Brunt EM, Loomba R, Lavine JE, Schwimmer JB, Sirlin CB. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013; 267: 422-431 [PMID: 23382291 DOI: 10.1148/radiol.12120896]
15. Larson-Meyer DE, Newcomer BR, VanVrancken-Tompkins CL, Sothern M. Feasibility of assessing liver lipid by proton magnetic resonance spectroscopy in healthy normal and overweight prepubertal children. Diabetes Technol Ther 2010; 12: 207-212 [PMID: 20151771 DOI: 10.1089/dia.2009.0069]
16. Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, Celik A, Bahar K, Karcaaltincaba M. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 2013; 267: 767-775 [PMID: 23382293 DOI: 10.1148/radiol.13121360]
17. Demerath EW, Ritter KJ, Couch WA, Rogers NL, Moreno GM, Choh A, Lee M, Remsberg K, Czerwinski SA, Chumlea WC, Siervogel RM, Towne B. Validity of a new automated software program for visceral adipose tissue estimation. Int J Obes (Lond) 2007; 31: 285-291 [PMID: 16770332 DOI: 10.1038/sj.ijo.0803409]
18. Ross R, Freeman J, Hudson R, Janssen I. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab 2002; 87: 5044-5051 [PMID: 12414870 DOI: 10.1210/jc.2002-020570]
19. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21: 3-16 [PMID: 11296695 DOI: 10.1055/s-2001-12925]
20. Guiu B, Petit JM, Loffroy R, Ben Salem D, Aho S, Masson D, Hillon P, Krause D, Cercueil JP. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 2009; 250: 95-102 [PMID: 19092092 DOI: 10.1148/radiol.2493080217]
21. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, Zoli M, Marchesini G. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42: 473-480 [PMID: 15981216 DOI: 10.1002/hep.20781]
22. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-1350 [PMID: 20879883 DOI: 10.1056/NEJMra0912063]
23. Pacifico L, Di Martino M, De Merulis A, Bezzi M, Osborn JF, Catalano C, Chiesa C. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. Hepatology 2014; 59: 461-470 [PMID: 23843206 DOI: 10.1002/hep.26610]
24. Santoro N, Caprio S. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in obese adolescents: A looming marker of cardiac dysfunction. Hepatology 2014; 59: 372-374 [PMID: 23913480 DOI: 10.1002/hep.26663]
25. Sagi R, Reif S, Neuman G, Webb M, Phillip M, Shalitin S. Nonalcoholic fatty liver disease in overweight children and adolescents. Acta Paediatr 2007; 96: 1209-1213 [PMID: 17655622 DOI: 10.1111/j.1651-2227.2007.00399.x]
26. Taksali SE, Caprio S, Dziura J, Dufour S, Calí AM, Goodman TR, Papademetris X, Burgert TS, Pierpont BM, Savoye M, Shaw M, Seyal AA, Weiss R. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: A determinant of an adverse metabolic phenotype. Diabetes 2008; 57: 367-371 [PMID: 17977954 DOI: 10.2337/db07-0932]
27. Maffeis C, Manfredi R, Trombetta M, Sordelli S, Storti M, Benuzzi T, Bonadonna RC. Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. J Clin Endocrinol Metab 2008; 93: 2122-2128 [PMID: 18397988 DOI: 10.1210/jc.2007-2089]
28. Fonvig CE, Bille DS, Chabanova E, Nielsen TR, Thomsen HS, Holm JC. Muscle fat content and abdominal adipose tissue distribuition investigated by magnetic resonance spectroscopy and imaging in obese children and youths. Pediatr Rep 2012; 4: e11
29. Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, Lundbom N, Rissanen A, Ridderstrale M, Groop L, Orho-Melander M, Yki-Järvinen H. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 2009; 137: 865-872 [PMID: 19524579 DOI: 10.1053/j.gastro.2009.06.005]
30. Longo R, Pollesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, Crocè LS, Grigolato P, Paoletti S, de Bernard B. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995; 5: 281-285 [PMID: 7633104 DOI: 10.1002/jmri.1880050311]
31. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999; 276: E977-E989 [PMID: 10329993]
32. van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, van Gulik TM, Stoker J. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 2010; 256: 159-168 [PMID: 20574093 DOI: 10.1148/radiol.10091790]
33. Chalasani N. Nonalcoholic fatty liver disease liver fat score and fat equation to predict and quantitate hepatic steatosis: promising but not prime time! Gastroenterology 2009; 137: 772-775 [PMID: 19638269 DOI: 10.1053/j.gastro.2009.07.032]
34. Springer F, Machann J, Claussen CD, Schick F, Schwenzer NF. Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol 2010; 16: 1560-1566 [DOI: 10.3748/wjg.v16.i13.1560]
35. Reeder SB, Robson PM, Yu H, Shimakawa A, Hines CD, McKenzie CA, Brittain JH. Quantification of hepatic steatosis with MRI: The effects of accurate fat spectral modeling. J Magn Reson Imaging 2009; 29: 1332-1339 [PMID: 19472390 DOI: 10.1002/jmri.21751]
36. Machann J, Thamer C, Schnoedt B, Stefan N, Haring HU, Claussen CD, Fritsche A, Schick F. Hepatic lipid accumulation in healthy subjects: A comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 2006; 55: 913-917 [PMID: 16506186 DOI: 10.1002/mrm.20825]
37. Cowin GJ, Jonsson JR, Bauer JD, Ash S, Ali A, Osland EJ, Purdie DM, Clouston AD, Powell EE, Galloway GJ. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 2008; 28: 937-945 [PMID: 18821619 DOI: 10.1002/jmri.21542]
38. Yokoo T, Bydder M, Hamilton G, Middleton MS, Gamst AC, Wolfson T, Hassanein T, Patton HM, Lavine JE, Schwimmer JB, Sirlin CB. Nonalcoholic fatty liver disease: diagnostic and fatgrading accuracy of low-flip-angle multiecho gradient-recalledecho MR imaging at 1.5 T. Radiology 2009; 251: 67-76 [PMID: 19221054 DOI: 10.1148/radiol.2511080666]
39. Africa JA, Newton KP, Schwimmer JB. Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children. Dig Dis Sci 2016; 61: 1375-1386 [PMID: 27041377 DOI: 10.1007/s10620-016-4126-1]
40. Rehm JL, Wolfgram PM, Hernando D, Eickhoff JC, Allen DB, Reeder SB. Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol 2015; 25: 2921-2930 [PMID: 25916386 DOI: 10.1007/s00330-015-3724-1]